TY  - GEN
AU  - Hu,Zishuo Ian
AU  - Bendell,Johanna C
AU  - Bullock,Andrea
AU  - LoConte,Noelle K
AU  - Hatoum,Hassan
AU  - Ritch,Paul
AU  - Hool,Hugo
AU  - Leach,Joseph W
AU  - Sanchez,James
AU  - Sohal,Davendra P S
AU  - Strickler,John
AU  - Patel,Ravindranath
AU  - Wang-Gillam,Andrea
AU  - Firdaus,Irfan
AU  - Yu,Kenneth H
AU  - Kapoun,Ann M
AU  - Holmgren,Eric
AU  - Zhou,Lei
AU  - Dupont,Jakob
AU  - Picozzi,Vincent
AU  - Sahai,Vaibhav
AU  - O'Reilly,Eileen M
TI  - A randomized phase II trial of nab-paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer
SN  - 2045-7634
PY  - 2020///0902
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Albumins
KW  - administration & dosage
KW  - Antibodies, Monoclonal
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - adverse effects
KW  - Biomarkers
KW  - Deoxycytidine
KW  - Disease Management
KW  - Female
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Male
KW  - Middle Aged
KW  - Molecular Targeted Therapy
KW  - Paclitaxel
KW  - Pancreatic Neoplasms
KW  - drug therapy
KW  - Prognosis
KW  - Receptor, Notch2
KW  - antagonists & inhibitors
KW  - Receptor, Notch3
KW  - Treatment Outcome
KW  - Gemcitabine
N1  - Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1002/cam4.2425
ER  -